CGRP receptor antagonists
Abstract:
The disclosures herein relate to novel compounds of formula wherein R1, R2 and R3 are as defined herein, and their use in treating, preventing, ameliorating, controlling or reducing cerebrovascular or vascular disorders associated with CGRP receptor function.
Public/Granted literature
Information query
Patent Agency Ranking
0/0